Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inmed Pharmaceuticals Inc (NQ: INM ) 0.3950 -0.0050 (-1.25%) Streaming Delayed Price Updated: 12:17 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,316,785 Open 0.4100 Bid (Size) 0.3855 (13) Ask (Size) 0.3997 (2) Prev. Close 0.4000 Today's Range 0.3840 - 0.4688 52wk Range 0.1207 - 2.080 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket August 22, 2024 Via Benzinga CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuances August 21, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Performance YTD +1.28% +1.28% 1 Month +36.92% +36.92% 3 Month +37.39% +37.39% 6 Month -8.10% -8.10% 1 Year -51.29% -51.29% More News Read More Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket August 21, 2024 Via Benzinga Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings August 20, 2024 Via Benzinga Exposures Fossil Fuels Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings August 20, 2024 Via Benzinga BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment August 20, 2024 Via Investor Brand Network InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday August 20, 2024 Via Benzinga US Stocks Mixed; Lowe's Cuts FY24 Forecast August 20, 2024 Via Benzinga BioMedNewsBreaks — InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD August 16, 2024 Via Investor Brand Network InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids” August 07, 2024 Via CannabisNewsWire Topics Cannabis Exposures Cannabis InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids” August 07, 2024 Via Investor Brand Network Topics Cannabis Exposures Cannabis BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD July 30, 2024 Via Investor Brand Network InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration July 24, 2024 Via Investor Brand Network InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration July 24, 2024 Via CannabisNewsWire The Rising Importance Of Minor Cannabinoids In The Growing Edible Market July 19, 2024 Via News Direct Topics Cannabis Exposures Cannabis BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment July 11, 2024 Via Investor Brand Network 7 F-Rated Growth Stocks to Avoid Right Now: June 2024 June 28, 2024 Via InvestorPlace InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases June 14, 2024 Via Investor Brand Network BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference June 11, 2024 Via Investor Brand Network Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket June 06, 2024 Via Benzinga Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 06, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday June 06, 2024 Via InvestorPlace INM Stock Earnings: InMed Pharmaceuticals Reported Results for Q3 2024 May 14, 2024 Via InvestorPlace CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial Results, Business Update May 14, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic Abilities May 07, 2024 Via News Direct Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
